I think it will be great if they can reactivate human atopic dermatitis trials based on the canine study.
It was really a big set back when they failed to see positive results on the previous phase 2 trial despite promising findings during phase 1.
I think atopic dermatitis, and probably acne as well, require a higher strength CBD, the one they are going to try at the Rosacea trial.
BOT - Anything but charting, page-2769
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.8¢ |
Change
0.023(5.42%) |
Mkt cap ! $766.4M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 44.0¢ | 41.5¢ | $2.716M | 6.319M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 51067 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 263209 | 17 |
View Market Depth
| Last trade - 13.34pm 09/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |